Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PiggyBac transposable element derived 4 pseudogene 4 (PGBD4P4) is annotated as a human pseudogene, located on the genome but lacking coding potential for functional proteins[1]. It appears to be derived from a piggyBac transposable element, a type of DNA transposon notable for precise excision and TTAA integration but has no established role as a protein or enzyme in human biology[3][5]. There is no evidence it acts as a receptor, transporter, or direct drug target. Current scientific databases do not associate PGBD4P4 with any therapeutic relevance, functional protein product, or disease—apart from it being a non-coding gene. Its connection to functional biology or clinical application remains undefined, and any biological role would be speculative or based on analogy to other pseudogenes[1][4]. Note: There is another pseudogene, *PA2G4P4*, sometimes confused as a cancer biomarker or candidate for study in bladder cancer, but no such evidence is available for PGBD4P4. The two should not be conflated[2][4].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PiggyBac transposable element derived 4 pseudogene 4 (PGBD4P4).